Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)
- Target
- NNRTI
- Molecular classification
- Small molecule drug, Reverse transcriptase inhibitor
01
Overview
NNRTIs represent a key class of antiretroviral agents that block HIV replication by binding noncompetitively to an allosteric site on the viral reverse transcriptase enzyme. This action prevents conversion of viral RNA into proviral DNA without being incorporated themselves or requiring activation via phosphorylation. Their unique mechanism distinguishes them from other classes such as NTRTIs/NtTRTIs and underpins their role in modern combination ART regimens for treating HIV/AIDS.
- Other names
- Non-nucleoside analogue reverse transcriptase inhibitor
02
Mechanism of action
Allosteric inhibition of HIV-1 reverse transcriptase, preventing viral RNA from being converted into DNA.
03
Biological functions
Inhibition of reverse transcriptase activityAntiretroviral activity
04
Disease associations
HIV infectionAIDS
05
Safety considerations
Drug-drug interactions due to CYP enzyme modulationDevelopment of drug resistance
06
Interacting drugs
Nevirapine
2 more in the full profile.
Beyond the preview
Go deeper on Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI).